Camizestrant (AZD-9833) is an effective oral antagonist of the active estrogen receptor (ER). Camizestrant can be used in the study of ER+ HER2- breast cancer.
Molecular Weight:
476.51
Purity:
>98.0%
CAS Number:
[2222844-89-3]
Formula:
C24H28F4N6
Target:
Estrogen Receptor
* VAT and and shipping costs not included. Errors and price changes excepted